Fractional Laser for Carcinomas: Breakthrough New Treatment

Bruce Robinson, MD is pioneering a transformative new treatment option for the most common forms of skin cancer: Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC).

It involves a combination of Fractional Laser therapy and topical medication. The results have been dramatic: almost complete elimination of BCCs and SCCs, requiring only ONE very short treatment, with minimal disruption for the patient, and an excellent visual end result.

The use of fractional lasers to wipe out BCCs or SCCs promises to open a whole new chapter in skin cancer treatment, and Dr. Robinson is expanding his research and healing in this area.

Basal Cell Carcinoma is the most common form of skin cancer – in fact it is the most common form of any cancer, with 3.6 million cases diagnosed yearly. BCC is slow growing and can be cured if dealt with early. However, if left untreated, BCC can grow locally and reoccur.

Past treatments have included surgical excision, freezing, topical creams, even radiation. However, since 2023 Bruce Robinson, MD has been pioneering a new approach using fractional lasers on the skin followed by topical medication. With this combination he has achieved remarkable results, including a cancer clearing rate approaching 100% upon follow-up visits.

Basal or squamous cell carcinomas are not the same as melanoma skin cancer. They are most often a result of sun damage. As the most common forms of skin cancer, they account for 90% of skin cancers in the U.S. Traditional therapies have included:

• Cutting out or “excising” the tumor (including Mohs surgery), which includes removing a small surrounding area of normal-appearing skin and sending it to a lab. If lab results reveal cancer cells in the area around the tumor, more skin may need to be removed.
• Scraping the tumor away and using electricity to kill cancer cells, also known as "curettage and desiccation."
• Freezing cancer cells, known as "cryosurgery" using liquid nitrogen.

Dr. Robinson’s unique approach combines Fractional Laser therapy alongside proven topical medication. Fractional lasers have been used by dermatologists for decades to treat minor facial flaws and improve skin appearance. Dr. Robinson’s breakthrough approach has been to extend their use deeper into the skin to kill off cancer cells while minimizing damage to surrounding cells. The non-ablative fractional laser promises to be a new and innovative approach to skin cancer treatment without excision or stitches, risk of infection, physical limitations, or prolonged recovery time. Dr. Robinson is currently expanding his research and notable advancement in skin cancer treatment using these novel approaches and targeted therapies to improve patient outcomes and survival rates.